{"id":"W4361295263","doi":"10.1186/s13046-023-02649-6","title":"First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumors","year":2023,"lang":"en","type":"article","venue":"Journal of Experimental & Clinical Cancer Research","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"Precision BioLogic (Canada)","funders":"National Cancer Institute","keywords":"Medicine; Neutropenia; Internal medicine; Febrile neutropenia; Pharmacokinetics; Gastroenterology; Clinical trial; Refractory (planetary science); Oncology; Toxicity","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002197073,0.001882984,0.001805242,0.0003407943,0.0005354263,0.0009426631,0.0008507023,0.001426751,0.003952808],"category_scores_gemma":[0.0009734923,0.0005402273,0.0009244159,0.0002863139,0.001125596,0.0008219684,0.0003893494,0.00365138,0.0008900168],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001169154,"about_ca_system_score_gemma":0.00191319,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006864876,"about_ca_topic_score_gemma":0.002256799,"domain_scores_codex":[0.9994678,0.0002808447,0.00002218904,0.00006216829,0.00004573597,0.0001212875],"domain_scores_gemma":[0.9990405,0.0001835478,0.0002054985,0.00007197025,0.00006602101,0.0004323873],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6830726,0.125523,0.00821606,0.001441745,0.001058666,0.0007393974,0.0005897779,0.003694989,0.07687326,0.0004392739,0.009356799,0.08899456],"study_design_scores_gemma":[0.3678689,0.613797,0.005951501,0.00004207182,0.0001928034,0.0003749089,0.00004710198,0.001095537,0.00714591,0.0002275577,0.003231999,0.00002462946],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9895496,0.001741355,0.0007678287,0.0005590246,0.0001165526,0.00420328,0.001235754,0.00009736636,0.001729242],"genre_scores_gemma":[0.9833059,0.001329084,0.002352225,0.001384402,0.0002362741,0.004433116,0.002839379,0.00004270485,0.004076847],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003952808,"threshold_uncertainty_score":0.01322341,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2503249849082375,"score_gpt":0.5989433629434179,"score_spread":0.3486183780351804,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}